1. Contractors
  2. Akina, Inc.

Akina, Inc.

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Akina has 1 federal contract of $100,000 or more active since October 2023, with $1.21M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
1 since FY2024$1,211,682 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Food and Drug Administration$1.21M on 1 contract
UEI
WTBLC3LE13U1Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
This Is a Firm Fixed Price Fornew Plga Analytical Methods for Mini-Size Complex Long-Acting Injectable Formulations.Food and Drug Administration · 75F40123C00192$1,211,682Dec 31, 2026in 1 monthIN

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Food and Drug Administration1 contract$1,211,682

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract$1,211,682

Where the work is

Place of workAmount
Indiana1 contract$1,211,682

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.

Get new notices like Akina's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy